August22 , 2026

    PLUSS launches two new temp-controlled pharma packaging solutions

    Related

    MV Densa Eagle Berths at Deendayal Port with 47,250 MT of Granular Urea

    MV Densa Eagle has berthed at Deendayal Port, Kandla,...

    VOC Port Conducts 2nd Annual ISPS Code Statement of Compliance Audit

    V.O. Chidambaranar Port Authority underwent the 2nd Annual Statement...

    APSEZ Poised to Secure Dry Bulk Berths at Paradip Port

    Adani Ports and Special Economic Zone Ltd (APSEZ) is...

    India Boosts Air Cargo Efficiency with 20-Hour Transit Target

    India has significantly accelerated domestic-to-international air cargo transshipment by...

    Delhi Airport Expands Air Cargo Network to London and Copenhagen

    Delhi’s Indira Gandhi International Airport has expanded India’s domestic-to-international...

    Share

    The phase-change material (PCM) technology company Pluss Advanced Technologies (PLUSS), has announced the launch of two new temperature-controlled packaging solutions for the pharmaceutical industry: Celsure® XL Pallet Shipper series and Celsure® VIP Multi-Use Parcel Shipper series.

    The pharmaceutical industry in India has long struggled with the availability of premium quality passive shippers that can ensure consistent temperature control. Commonly used gel pack-based shippers, expose pharma products to a high risk of temperature deviation, compromising efficacy. Imported boxes and containers that are leased work out to be extremely expensive with their own logistical complexities.

    “Manufactured in India, Celsure® XL and Celsure® VIP offer a superior alternative to conventional gel pack solutions and expensive leased containers. Using our patented PCM technology we are able to ensure the safe and efficient transportation of temperature-sensitive pharmaceuticals in a sustainable manner. These solutions further strengthen India’s standing as a pharmacy of the world by increasing the supply chain reliability and ultimately delivering quality medicines to patients worldwide,” said Samit Jain, MD, PLUSS.